PH to donate 5 million Sputnik V vaccine doses to Myanmar | Inquirer

PH to donate 5 million Sputnik V vaccine doses to Myanmar

By: - Reporter /
/ 04:16 PM April 22, 2022

Sputnik V vaccine to Myanmar

Arrival of recent shipment of Sputnik V vaccine doses. Screenshot from PTV

MANILA, Philippines — Five million Sputnik V COVID-19 vaccine doses that are nearing the end of shelf life will be donated by the Philippine government to Myanmar, the Department of Health (DOH) said Friday.

Health Undersecretary Maria Rosario Vergeire said in an online media briefing that discussions with authorities in Myanmar are ongoing.

Article continues after this advertisement

“We have to go through a lot of processes but definitely ito pong sa Myanmar ay ongoing na talaga ng discussion… Ang ini-intend po na idonate sa Myanmar ‘yung mga Sputnik V components 1 and 2 and these will be worth around 5 million doses of vaccines,” she said.

FEATURED STORIES

Meanwhile, discussions with the government of Papua New Guinea have yet to start. Vergeire said it is just one of the proposed recipients of the excess vaccines.

Malacañang earlier said the Philippine government will go ahead with its plan to donate “excess” vaccines that are nearing the end of shelf life.

Article continues after this advertisement

Acting presidential spokesperson Martin Andanar said “legal documentation processes are ongoing” for the delivery of the donated vaccines to Myanmar.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the and acknowledge that I have read the .

business
business
globalnation
www
business
www
www
globalnation
business
business
TAGS: DoH, Myanmar, Sputnik V

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the and acknowledge that I have read the .

© Copyright 1997-2024 | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies.